Proprietary & Confidential—This material is proprietary to My Life Spark P.C. Unauthorized use, reproduction, or distribution is strictly prohibited.

About

We are My Life Spark, P.C.

A physician-owned medical practice and the operating company behind a national cancer survivorship model with a special emphasis on protecting the heart. Founded by clinicians who watched survivors finish treatment and fall into a follow-up gap — and decided to build the alternative.

Our Thesis

Survivors are living longer, and the heart is where too many of those years are lost.

There are more than 18 million cancer survivors in the United States, and the number grows every year. For several survivor groups, cardiovascular disease — not cancer recurrence — becomes the leading cause of death over time. Anthracyclines, HER2 therapies, chest radiation, androgen-deprivation therapy and immune checkpoint inhibitors all leave cardiac fingerprints that need to be followed for decades.

Yet when active treatment ends, ownership of that follow-up is unclear. Oncology visits taper. Primary care often receives no summary of exposures, no surveillance cadence, and no guidance on which symptoms matter. Survivors are told they are done, then left to coordinate the rest themselves.

My Life Spark exists to close that gap. A physician-owned PC structure, compliant in every state. A clinical protocol — the Life Spark Survivorship Protocol™ — covering cardiac surveillance, late-effects screening, and the metabolic changes treatment leaves behind. Metabolic health is part of the work here, not a separate business: it sits inside survivorship because weight, muscle, glucose, lipids and blood pressure after treatment are among the strongest modifiable drivers of heart risk.

We are not a wellness brand. We are a medical practice built around the years after cancer treatment.

Read the metabolic health after cancer subsection.

Clinical Advisory Board

Survivorship, authored by people who practice it.

Board-certified physicians authoring every protocol. Pharmacists overseeing deprescribing. Survivors on the board. Every recommendation traceable to NCCN, ASCO, or COG-LTFU guidance.

LP

Dr. Lena Park, MD

Chief Medical Officer

Board-certified internal medicine + cardio-oncology. Former clinical lead at an academic survivorship program.

MH

Dr. Marcus Hale, MD, PhD

Chair, Clinical Advisory Board

Medical oncology. 60+ peer-reviewed papers on long-term effects of cancer therapy and survivorship science.

PA

Dr. Priya Anand, MD, MPH

Preventive Cardiology

ApoB-first lipid management. Cardio-oncology surveillance after anthracyclines and chest RT.

JO

Dr. James O'Neil, PharmD, BCPS

Clinical Pharmacy

Deprescribing of treatment-era medications. Drug-drug interaction modeling for survivors.

SW

Sara Whitman, RD, CSSD

Survivorship Nutrition

Sarcopenia recovery, bone-health nutrition after treatment, and post-treatment metabolic rebuild.

RM

Rohan Mehta

Director, Institute Operations

Built patient-facing digital health platforms serving over a million users across three companies.

Safety & Compliance

Built for survivorship. Governed for trust.

Clinician-reviewed, guideline-aligned

Every surveillance plan is reviewed by a licensed clinician and mapped to NCCN, ASCO, and COG-LTFU guidance.

PHI access audit trail

Every view, export, and share of a survivor's chart is logged. Survivors can see who accessed their data and revoke access at any time.

HIPAA-ready infrastructure

Encrypted PHI at rest and in transit, SOC 2 Type II vendors, BAAs with every subprocessor, annual penetration testing. See our HIPAA readiness page for the current status of each feature.

Consent-scoped data sharing

Nothing leaves your account without an explicit action or an opt-in you can revoke. Automated FHIR sync is off until HIPAA readiness is complete.

Portable, patient-owned record

Your survivorship chart travels with you. Download it, share it, or hand a printable summary to any new clinician.

Independent clinical review

Protocols reviewed with our CSPN clinician network and refreshed against the peer-reviewed literature.

As featured in

JCO Oncology PracticeASCO PostSTAT NewsNEJM CatalystCancer TodayFierce HealthcareEndpointsAxios
“The first serious attempt to give every survivor a portable, guideline-aligned chart.”
— NEJM Catalyst
“The Institute is doing for survivorship what patient-owned records tried to do a decade ago — and finally getting the design right.”
— STAT News
“A meaningful step toward closing the AYA transition-of-care cliff.”
— ASCO Post